| ICI | Immune checkpoint inhibitor |
| PD-1 | Programmed Death-1 Receptor |
| CTLA-4 | Cytotoxic T Lymphocyte Associated Protein-4 |
| PD-L1 | Programmed Death Ligand-1 |
| irAEs | immune-related adverse events |
| ICI-DM | ICI-induced diabetes mellitus |
| ICI | Immune checkpoint inhibitor |
| PD-1 | Programmed Death-1 Receptor |
| CTLA-4 | Cytotoxic T Lymphocyte Associated Protein-4 |
| PD-L1 | Programmed Death Ligand-1 |
| irAEs | immune-related adverse events |
| ICI-DM | ICI-induced diabetes mellitus |